HCV and renal cell carcinoma: A new insight between HCV and oncogenesis? Report of five cases

Experimental Oncology

Volumn 25, Issue 1, 2003, Pages 77-78

  Di Micco, B ^a   Di Micco, P ^b  

^a UNIVERSITY OF SANNIO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

HCV; Oncogenesis; Renal cell carcinoma

Indexed keywords

AMINOTRANSFERASE; CD81 ANTIGEN;

AMINOTRANSFERASE BLOOD LEVEL; APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HEPATITIS C VIRUS; HUMAN; KIDNEY CARCINOMA; LETTER; TUMOR GROWTH; VIRUS REPLICATION; CANCER CELL; CANCER STAGING; CELL DAMAGE; CELL TYPE; LIVER DISEASE; UPREGULATION; VIRUS INFECTION;

EID: 0038371149     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (11)

1. Butenko ZA, Phylchenkov AA. Modern concepts of viral oncogenesis: fundamental and applied aspects. Exp Oncol 2000; 22: 239-45.
2. Cheng W. Human DNA oncogenic viruses and their transforming protein interactions with cell cycle control proteins. Chin Med J 1999; 112: 291-6.
3. Park JS, Yang JM, Min MK. Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene. Biochem Biophys Res Commun 2000; 267: 581-7.
4. Jovanovic J, Brkic S, Klasnja B, Fabri M. EpsteinBarr, hepatitis B and hepatitis C virus infections and their oncogenic potentials. Med Pregl 1997; 50: 499-504.
5. Patel AH, Wood J, Penin F, Dubuisson J, McKeating JA. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding. J Gen Virol 2000; 81: 2873-83.
6. El-Seraq HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002; 36: S74-83.
7. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36: S35-46.
8. De Rosa G, Gobbo ML, De Renzo A, Notaro R, Garofalo S, Grimaldi M, Apuzzo A, Chiurazzi F, Picardi M, Matarazzo M, Rotoli B. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol 1997; 55: 77-82.
9. Bruno G, Andreozzi P, Graf U, Santangelo G. Hepatitis C virus: a high risk factor for a second primary malignancy besides hepatocellular carcinoma. Fact or fiction? Clin Ther 1999; 150: 413-8.
10. Aoki K, Nakanou I, Takashima K, Hirao K, Hiramatsu T, Fuhimoto K, Kagebayashi Y, Ozono S, Hirao Y. A case of renal cell carcinoma producing alpha-fetoprotein. Hinyokika Kiyo 2001; 47: 477-80.
11. Aulitzky WE, Huber C, Peschel C. Cytokine therapy of neoplastic and inflammatory disease. Int Arch Allergy Immunol 1993; 101: 221-6.